Literature DB >> 7812278

The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?

J Ashby1, M O'Hanlon, M J Buxton.   

Abstract

The time trade-off method was incorporated into a study of valuation of health states following treatment for breast cancer. A major aim of the work was to determine whether different groups give different valuations. The time trade-off technique was simple and quick to administer, acceptable to subjects, and produced different values in different groups. Age and sex of valuers had some influence: the most striking differences were found between women who had experienced breast cancer and those who had not. The time trade-off method has considerable potential in health state valuation. The choice of valuers needs to be further explored.

Entities:  

Mesh:

Year:  1994        PMID: 7812278     DOI: 10.1007/bf00434899

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  13 in total

1.  Measuring the wellbeing of family caregivers using the time trade-off technique.

Authors:  E A Mohide; G W Torrance; D L Streiner; D M Pringle; R Gilbert
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

2.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

3.  The quality of survival in breast cancer: a case-control comparison.

Authors:  T J Craig; G W Comstock; P B Geiser
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

4.  A scale of valuations of states of illness: is there a social consensus?

Authors:  R Rosser; P Kind
Journal:  Int J Epidemiol       Date:  1978-12       Impact factor: 7.196

5.  Psychological response to breast cancer: effect on outcome.

Authors:  S Greer; T Morris; K W Pettingale
Journal:  Lancet       Date:  1979-10-13       Impact factor: 79.321

6.  Psychological and social adjustment to mastectomy: a two-year follow-up study.

Authors:  T Morris; H S Greer; P White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

7.  Adjuvant chemotherapy for breast carcinoma: psychosocial implications.

Authors:  B E Meyerowitz; F C Sparks; I K Spears
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

8.  Physical and psychologic readjustment after mastectomy: an evaluation of Memorial Hospitals' PMRG program.

Authors:  L Winick; G F Robbins
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

9.  Functional health status levels of primary care patients.

Authors:  E Nelson; B Conger; R Douglass; D Gephart; J Kirk; R Page; A Clark; K Johnson; K Stone; J Wasson; M Zubkoff
Journal:  JAMA       Date:  1983-06-24       Impact factor: 56.272

10.  Psychiatric problems in the first year after mastectomy.

Authors:  G P Maguire; E G Lee; D J Bevington; C S Küchemann; R J Crabtree; C E Cornell
Journal:  Br Med J       Date:  1978-04-15
View more
  17 in total

Review 1.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  The influence of ill-health experience on the valuation of health.

Authors:  X Badia; M Herdman; P Kind
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

3.  Quality of life related to fear of falling and hip fracture in older women: a time trade off study.

Authors:  G Salkeld; I D Cameron; R G Cumming; S Easter; J Seymour; S E Kurrle; S Quine
Journal:  BMJ       Date:  2000-02-05

4.  Long-term health investment when people underestimate their adaptation to old age-related health problems.

Authors:  Octave Jokung; Serge Macé
Journal:  Eur J Health Econ       Date:  2012-12-28

5.  Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy.

Authors:  S J Jansen; A M Stiggelbout; M A Nooij; E M Noordijk; J Kievit
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

6.  Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

Authors:  Jonathan Karnon; Jackie Brown
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Community perspectives on difference of sex development (DSD) diagnoses: A crowdsourced survey.

Authors:  M Hassan Alkazemi; Ashley W Johnston; Diane Meglin; Deanna Adkins; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2020-04-27       Impact factor: 1.830

8.  Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

Authors:  Ines Vaz-Luis; Anne O'Neill; Karen Sepucha; Kathy D Miller; Emily Baker; Chau T Dang; Donald W Northfelt; Eric P Winer; George W Sledge; Bryan Schneider; Ann H Partridge
Journal:  Cancer       Date:  2017-03-21       Impact factor: 6.860

9.  Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public.

Authors:  Peter A Ubel; George Loewenstein; Christopher Jepson
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

10.  Opinions on the treatment of people with tetraplegia: contrasting perceptions of physiatrists and hand surgeons.

Authors:  Catherine M Curtin; Jared P Wagner; David R Gater; Kevin C Chung
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.